The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 1 of 2
Back to Result List

COVID‐19 and implications for dermatological and allergological diseases

Please always quote using this URN: urn:nbn:de:bvb:20-opus-217860
  • COVID‐19, caused by the coronavirus SARS‐CoV‐2, has become pandemic. A further level of complexity opens up as soon as we look at diseases whose pathogenesis and therapy involve different immunological signaling pathways, which are potentially affected by COVID‐19. Medical treatments must often be reassessed and questioned in connection with this infection. This article summarizes the current knowledge of COVID‐19 in the light of major dermatological and allergological diseases. It identifies medical areas lacking sufficient data and drawsCOVID‐19, caused by the coronavirus SARS‐CoV‐2, has become pandemic. A further level of complexity opens up as soon as we look at diseases whose pathogenesis and therapy involve different immunological signaling pathways, which are potentially affected by COVID‐19. Medical treatments must often be reassessed and questioned in connection with this infection. This article summarizes the current knowledge of COVID‐19 in the light of major dermatological and allergological diseases. It identifies medical areas lacking sufficient data and draws conclusions for the management of our patients during the pandemic. We focus on common chronic inflammatory skin diseases with complex immunological pathogenesis: psoriasis, eczema including atopic dermatitis, type I allergies, autoimmune blistering and inflammatory connective tissue diseases, vasculitis, and skin cancers. Since several other inflammatory skin diseases display related or comparable immunological reactions, clustering of the various inflammatory dermatoses into different disease patterns may help with therapeutic decisions. Thus, following these patterns of skin inflammation, our review may supply treatment recommendations and thoughtful considerations for disease management even beyond the most frequent diseases discussed here.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Timo Buhl, Stefan Beissert, Evelyn Gaffal, Matthias Goebeler, Michael Hertl, Cornelia Mauch, Kristian Reich, Enno Schmidt, Michael P. Schön, Michael Sticherling, Cord Sunderkötter, Claudia Traidl‐Hoffmann, Thomas Werfel, Dagmar Wilsman‐Theis, Margitta Worm
URN:urn:nbn:de:bvb:20-opus-217860
Document Type:Journal article
Faculties:Medizinische Fakultät / Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie
Language:English
Parent Title (English):JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Year of Completion:2020
Volume:18
Issue:8
First Page:815
Last Page:824
Source:JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2020, 18(8):815-824. DOI: 10.1111/ddg.14195
DOI:https://doi.org/10.1111/ddg.14195
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:COVID-19; allergies; dermatology
Release Date:2021/07/20
Licence (German):License LogoCC BY-NC: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell 4.0 International